Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...

Ischemic Stroke l: Introduction

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Ischemic Stroke ll: Pathophysiology

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

Transient Ischemic Attack l: Introduction

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

miR-129-3p Targeting of MCU Protects Against Glucose Fluctuation-Mediated Neuronal Damage via a Mitochondrial-Dependent Intrinsic Apoptotic Pathway.

Diabetes, metabolic syndrome and obesity : targets and therapy·2021

Same author

Malignancy Risk Stratification Prediction of Amorphous Calcifications Based on Clinical and Mammographic Features.

Cancer management and research·2021

Same author

Comparison of clinical and histopathological characteristics of short-term progressive and non-progressive blood blister-like aneurysms.

Acta neurochirurgica·2021

Same author

Duration and choices of prophylactic anticonvulsants in subarachnoid hemorrhage: a systematic review and meta-analysis.

Neurosurgical review·2021

Same author

Changes in Characteristics, Treatment and Outcome in Patients with Hemorrhagic Stroke During COVID-19.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2020

Same author

Mass Detection and Segmentation in Digital Breast Tomosynthesis Using 3D-Mask Region-Based Convolutional Neural Network: A Comparative Analysis.

Frontiers in molecular biosciences·2020

Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026

Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026

Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026

Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026

Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026

Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 18, 2026

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Iron chelators for acute stroke.

Junpeng Ma¹, Chao You, Li Hao

¹Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.

The Cochrane Database of Systematic Reviews

|September 14, 2012

Summary

This summary is machine-generated.

Current research on iron chelators for stroke treatment is limited. No completed randomized controlled trials (RCTs) were found, indicating insufficient evidence to support their use in acute stroke patients.

More Related Videos

Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury

Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury

Published on: September 7, 2018

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique

Published on: December 15, 2023

Related Experiment Videos

Last Updated: May 18, 2026

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury

Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury

Published on: September 7, 2018

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique

Published on: December 15, 2023

Area of Science:

Neurology
Pharmacology
Public Health

Background:

Stroke represents a significant global health burden, causing widespread morbidity and mortality.
Iron chelators are being investigated as potential neuroprotective agents for both hemorrhagic and ischemic stroke.
Understanding the role of iron in stroke pathophysiology is crucial for developing effective treatments.

Purpose of the Study:

To systematically evaluate the efficacy and safety of iron chelator administration in patients experiencing acute stroke.
To synthesize evidence from randomized controlled trials (RCTs) regarding iron chelator therapy for stroke.
To identify gaps in current research and guide future clinical investigations.

Main Methods:

Comprehensive literature search across multiple databases including Cochrane, MEDLINE, EMBASE, and Science Citation Index up to May 2012.
Inclusion of published and unpublished randomized controlled trials (RCTs) comparing iron chelators with placebo or no treatment in acute stroke.
Independent screening and selection of trials by two review authors to ensure rigorous methodology.

Main Results:

No completed randomized controlled trials (RCTs) met the inclusion criteria for this review.
One ongoing RCT was identified, but no data were available at the time of the review.
The current evidence base for iron chelators in acute stroke treatment is critically lacking.

Conclusions:

There is insufficient evidence to either support or refute the use of iron chelators in the management of acute stroke.
Further high-quality randomized controlled trials (RCTs) are necessary to determine the potential benefits and risks of iron chelators for stroke patients.
Future research should focus on well-designed RCTs to establish the role of iron chelators in neuroprotection and stroke recovery.